Literature DB >> 8179486

Bacterial mutagenicity of 2-chloro-1,3-butadiene (chloroprene) caused by decomposition products.

G A Westphal1, M Blaszkewicz, M Leutbecher, A Müller, E Hallier, H M Bolt.   

Abstract

Since the literature on genotoxicity of 2-chloro-1,3-butadiene (chloroprene) is controversial, the mutagenicity of this compound was reinvestigated with respect to its chemical stability. Because of the volatility of chloroprene, Ames tests with S. typhimurium TA 100 were carried out with gas-tight preincubation. Propylene oxide, a volatile direct mutagen, served as a positive control. Benzo[a]pyrene was used as a control for an indirect mutagen. Using this experimental regimen, freshly distilled chloroprene was not mutagenic. However, a mutagenic effect occurred linearly with increasing age of the chloroprene distillates. Aged chloroprene gave the same positive results whether preincubation was gas-tight or not. Analysis by gas chromatography (GC) revealed several decomposition products in aged chloroprene distillates. The direct mutagenicity towards TA 100 correlated with the integrated amounts of four of these substances; these substances always occurred in the same relative ratio. When chloroprene was kept under anaerobic conditions, products occurred with time which were partly different from those obtained under aerobic conditions. The direct mutagenicity of anaerobically aged chloroprene was only weak, but the mutagenic effect was enhanced about two- to threefold by addition of S9 mix. Partial identification of chloroprene decomposition products was done by gas chromatography-mass spectrometry (GC-MS): major byproducts of chloroprene, probably responsible for mutagenic properties of aged chloroprene samples, were cyclic chloroprene dimers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8179486     DOI: 10.1007/s002040050038

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  7 in total

1.  Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium.

Authors:  H Bartsch; C Malaveille; R Montesano; L Tomatis
Journal:  Nature       Date:  1975-06-19       Impact factor: 49.962

2.  Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadienes and dichlorobutenes produced by rodent or human liver tissues. Evidence for oxirane formation by P450-linked microsomal mono-oxygenases.

Authors:  H Bartsch; C Malaveille; A Barbin; G Planche
Journal:  Arch Toxicol       Date:  1979-02-23       Impact factor: 5.153

3.  Angiosarcoma of liver in the manufacture of polyvinyl chloride.

Authors:  J L Creech; M N Johnson
Journal:  J Occup Med       Date:  1974-03

4.  Short-term test for the induction of lung tumor in mouse by chloroprene.

Authors:  Q A Dong; B L Xiao; Y H Hu; S Q Li
Journal:  Biomed Environ Sci       Date:  1989-06       Impact factor: 3.118

5.  Threshold levels in toxicology: significance of inactivation mechanisms.

Authors:  H Greim; U Andrae; W Göggelmann; S Hesse; L R Schwarz; K H Summer
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

6.  Mutagenic activity of propylene oxide in bacterial and mammalian systems.

Authors:  J Bootman; D C Lodge; H E Whalley
Journal:  Mutat Res       Date:  1979-06       Impact factor: 2.433

7.  Mutagenicity of vinyl chloride, vinylidene chloride and chloroprene in V79 Chinese hamster cells.

Authors:  C Drevon; T Kuroki
Journal:  Mutat Res       Date:  1979-06       Impact factor: 2.433

  7 in total
  2 in total

1.  Amylenes do not lead to bacterial mutagenicity in contrast to structurally related epoxides.

Authors:  Götz A Westphal; Carolin Tüshaus; Christian Monsé; Nina Rosenkranz; Thomas Brüning; Jürgen Bünger
Journal:  Biomed Res Int       Date:  2014-01-06       Impact factor: 3.411

Review 2.  Extended Analysis and Evidence Integration of Chloroprene as a Human Carcinogen.

Authors:  Sonja N Sax; P Robinan Gentry; Cynthia Van Landingham; Harvey J Clewell; Kenneth A Mundt
Journal:  Risk Anal       Date:  2019-09-16       Impact factor: 4.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.